NASDAQ: SNDX - Syndax Pharmaceuticals, Inc.

Yield per half year: -37.22%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Syndax Pharmaceuticals, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc., биофармацевтическая компания клинической стадии, разрабатывает методы лечения рака. Его ведущим продуктом-кандидатом является SNDX-5613, который находится на стадии 1/2 клинических испытаний, направленных на связывающее взаимодействие менина с белком лейкемии 1 смешанного происхождения для лечения MLL-реаранжированного (MLLr) и мутантного нуклеофозмина 1 острого миелоидного лейкоза (NPM1c).

more details
ПОД); и SNDX-6352 или аксатилимаб, моноклональное антитело, которое блокирует колониестимулирующий фактор 1 или рецептор CSF-1 для лечения пациентов с хронической реакцией «трансплантат против хозяина» (cGVHD). Компания также разрабатывает Entinostat. Он также имеет соглашение о совместных исследованиях и разработках с Национальным институтом рака; соглашение о клинических испытаниях с Восточной кооперативной онкологической группой; и лицензионное соглашение с Kyowa Hakko Kirin Co., Ltd. Syndax Pharmaceuticals, Inc. была зарегистрирована в 2005 году и имеет штаб-квартиру в Уолтеме, штат Массачусетс, штат Массачусетс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2016-03-03
ISIN US87164F1057
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.syndax.com
Цена ао 13.11
Change price per day: 0% (14.25)
Change price per week: +8.94% (13.08)
Change price per month: +10.25% (12.925)
Change price per 3 month: -25.82% (19.21)
Change price per half year: -37.22% (22.7)
Change price per year: -32.46% (21.1)
Change price per 3 year: -13.32% (16.44)
Change price per 5 year: +62.3% (8.78)
Change price per 10 year: 0% (14.25)
Change price per year to date: +9.03% (13.07)
All parameters

Underestimation

Title Value Grade
P/S 12.01 1
P/BV 2.66 6
P/E 0 0
EV/EBITDA -5.13 0
Total: 4.25

Efficiency

Title Value Grade
ROA, % -34.16 0
ROE, % -37.78 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0071 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 8245.42 10
Yield Ebitda, % 310.94 10
Yield EPS, % 66.56 8
Total: 9.6
More

Institutions Volume Share, %
Wellington Management Group, LLP 7585221 8.93
Blackrock Inc. 7015548 8.26
Kynam Capital Management, LP 5660000 6.66
State Street Corporation 5016224 5.9
Vanguard Group Inc 4335353 5.1
Avoro Capital Advisors LLC 4222222 4.97
Avidity Partners Management, LP 3950000 4.65
Eversept Partners, LP 3383244 3.98
Point72 Asset Management, L.P. 2834499 3.34
T. Rowe Price Investment Management, Inc. 2711253 3.19

ETF Share, % Profitability for 1 year, % Dividends, %
Range Cancer Therapeutics ETF 1.08629 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.69876 63.04 0.33
Simplify Health Care ETF 0.35854 27.81 1.00373
Direxion Daily S&P Biotech Bull 3x Shares 0.26987 4067.92 0.25924
Inspire Small/Mid Cap ETF 0.16577 28.65 1.92038
Invesco Nasdaq Biotechnology ETF 0.15247 28.58 0.8565
Future Tech ETF 0.15062 426.34 0.8416
Principal Healthcare Innovators ETF 0.15062 618.5 0.8416
Vanguard Russell 2000 Growth ETF 0.13 23.05 0.60264
iShares Russell 2000 Growth ETF 0.11111 38.04 0.6026
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.10386 24.75 1.59225
ProShares Ultra Nasdaq Biotechnology 0.10163 51.7 0.85651
Vanguard Russell 2000 ETF 0.06 17.16 1.48801
Nuveen ESG Small-Cap ETF 0.0543 13.91 1.41019
iShares ESG Aware MSCI USA Small-Cap ETF 0.04627 18.09 1.49366
Schwab U.S. Small-Cap ETF 0.03923 17.47 1.51433
iShares Morningstar Small-Cap Growth ETF 0.03547 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.03547 587.89 0.72598
iShares Morningstar Small-Cap ETF 0.03325 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.03325 30.1 1.60498
iShares Morningstar Small Cap Value ETF 0.03259 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.03259 201.65 2.50476
ProShares UltraPro Russell2000 0.03243 89.82 1.47873
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.0267 31.36 1.41955
Fidelity MSCI Health Care Index ETF 0.02091 3 1.46057
ProShares Hedge Replication ETF 0.00903 5.92 1.47892
Humankind US Stock ETF 0.0081 18.81 1.99919
SPDR Portfolio MSCI Global Stock Market ETF 0.0028 17.99 2.19607
Schwab U.S. Broad Market ETF 0.00258 24.86 1.43354
Avantis U.S. Equity ETF 0.00252 23.04 1.59151
iShares Russell 3000 ETF 0.00243 24.83 1.43482
Dimensional U.S. Core Equity 2 ETF 0.00218 30.76 1.47098
Dimensional U.S. Equity ETF 0.00129 31.53 1.3557
Dimensional US Core Equity Market ETF 0.00064 30.98 1.40618
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Michael A. Metzger M.B.A. CEO & Director 1.05M 1971 (54 years)
Dr. Peter Ordentlich B.Sc., Ph.D. Co-Founder & Chief Scientific Officer N/A 1969 (56 years)
Dr. Richard A. Heyman Ph.D. Co-Founder N/A 1957 (68 years)
Dr. Ronald M. Evans Ph.D. Co-Founder, Advisor and Chair of Scientific Advisory Board N/A 1949 (76 years)
Dr. Michael Downes Ph.D. Co-Founder N/A
Mr. Keith Alan Goldan CPA CFO, Treasurer & Chief Accounting Officer 649.07k 1971 (54 years)
Sharon Klahre Vice President of Investor Relations & Communications N/A
Mr. Luke J. Albrecht Senior VP, General Counsel & Secretary 605.82k 1979 (46 years)
Dr. Catherine Madigan M.D. Chief Medical Officer 764.41k 1972 (53 years)
Dr. Neil Gallagher M.D., Ph.D. President, Head of Research & Development N/A 1964 (61 year)

Address: United States, Waltham. MA, 35 Gatehouse Drive - open in Google maps, open in Yandex maps
Website: https://www.syndax.com